Abstract 1503P
Background
Spirituality is important in cancer care. Few studies have assessed the spiritual needs (SN) of cancer patients. The purpose of this study was to assess the SN of patients undergoing curative or palliative cancer treatments, and to evaluate the relationship between SN and their health-related quality of life (QOL).
Methods
We conducted a cross-sectional study using a brief questionnaire on the healthcare team's approach to spirituality, the Duke University Religion Index (DUREL), the Functional Assessment of Chronic Illness Therapy Spiritual Well Being Version 4 (FACIT-SP), and the Spiritual Needs Assessment for Patients (SNAP) in outpatient adults with solid tumors undergoing curative-intent or palliative cancer treatments. Informed consent was obtained from all patients.
Results
From March to October/2022, 150 patients were included: 75 receiving curative-intent treatment and 75, palliative. Patients who wanted a spirituality approach by the healthcare team had higher total SN and psychosocial, spiritual, and religious scores than patients who did not want it (p < 0.0001), but lower QOL scores (FACIT-G p = 0.001 and FACIT-SP p = 0.004). SN or QOL did not differ according to treatment intention (p = 0,444 and p = 0,159 respectively), age (r = 0,059), education level (p = 0,999), sex (p = 0,186), or marital status (p = 0,528). There was a predominant weak correlation between SN and QOL (r < 0,4); a moderate negative relationship between emotional well-being and spiritual domain needs (r = -0,416); a weak correlation between SN and the three dimensions of DUREL (r < 0,4); a moderate positive relationship (0,461 < r < 0,616) between faith subscale of spiritual well-being and the three dimensions of DUREL; and also, a moderate positive relationship (r = 0,410) between spiritual well-being and intrinsic religiosity.
Conclusions
In our study, patients who wanted a spiritual approach from the healthcare team had higher SN and lower QOL. SN were not related to cancer treatment intentions or the patient religiosity. Assessment of spirituality may improve cancer care, and further studies could evaluate screening and interventions in this area.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1501P - Sex-specific variation in symptoms presentation: Experience of an outpatient clinic integrated model between radiotherapy and palliative care
Presenter: Luca Tontini
Session: Poster session 10
1502P - Sexual dysfunction and quality of life in rectal cancer
Presenter: Fatih Kus
Session: Poster session 10
1546P - Use of ESMO-MCBS Scorecards in supporting funding decisions in private insurance
Presenter: Samantha Field
Session: Poster session 10
1547P - Time from approval to reimbursement of new cancer and non-cancer drugs: A comparative analysis between the US, England, Germany, and Switzerland (2011-2022)
Presenter: Camille Glaus
Session: Poster session 10
1548P - Real-world impact of the platinum chemotherapy shortage on advanced cancer patients
Presenter: Jacob Reibel
Session: Poster session 10
1549P - Accelerating access to innovative oncology drugs: Insights from France's early access reform
Presenter: Tess Martin
Session: Poster session 10
1550P - Addressing uncertainties of clinical value and improving access for newly authorised indications through DRUG-Access Protocol (DAP)-like platforms: Joint collection and evaluation of real-world evidence
Presenter: Sahar van Waalwijk van Doorn-Khosrovani
Session: Poster session 10
1551P - Breakthrough therapy cancer drugs and indications with FDA approval: Development time, innovation, trials, clinical benefit, epidemiology, and price
Presenter: Christoph Michaeli
Session: Poster session 10
1552P - Regulatory approval of novel immunotherapy for lymphoid neoplasm in the US, EU, and Japan
Presenter: Kensuke Matsuda
Session: Poster session 10
1553P - Access to EMA approved drugs in Europe, disparities across a border
Presenter: Orla Fitzpatrick
Session: Poster session 10